Your browser doesn't support javascript.
loading
Cardiovascular toxicity in patients with chronic myeloid leukemia treated with second-generation tyrosine kinase inhibitors in the real-life practice: Identification of risk factors and the role of prophylaxis.
Caocci, Giovanni; Mulas, Olga; Annunziata, Mario; Luciano, Luigiana; Bonifacio, Massimiliano; Orlandi, Ester Maria; Pregno, Patrizia; Galimberti, Sara; Russo Rossi, Antonella; Abruzzese, Elisabetta; Iurlo, Alessandra; Martino, Bruno; Sgherza, Nicola; Binotto, Gianni; Castagnetti, Fausto; Gozzini, Antonella; Fozza, Claudio; Bocchia, Monica; Sicuranza, Anna; Stagno, Fabio; Efficace, Fabio; Usala, Emilio; De Gregorio, Fiorenza; Scaffidi, Luigi; Elena, Chiara; Pirillo, Francesca; Baratè, Claudia; Trawinska, Malgorzata Monika; Cattaneo, Daniele; Labate, Claudia; Gugliotta, Gabriele; Molica, Matteo; Specchia, Giorgina; La Nasa, Giorgio; Foà, Robin; Breccia, Massimo.
Afiliación
  • Caocci G; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari.
  • Mulas O; Businco Hospital, Hematology and Transplant Center, Cagliari.
  • Annunziata M; Hematology Unit, Cardarelli Hospital, Naples.
  • Luciano L; Hematology Unit "Federico II" University of Naples, Naples.
  • Bonifacio M; Department of Medicine, Section of Hematology, University of Verona, Verona.
  • Orlandi EM; Hematology Unit, "Fondazione IRCCS Policlinico S. Matteo" University Hospital, Pavia.
  • Pregno P; Hematology Unit, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino.
  • Galimberti S; Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa.
  • Russo Rossi A; Hematology and Transplants Unit, University of Bari, Bari.
  • Abruzzese E; Hematology Unit, Sant'Eugenio Hospital Tor Vergata University, Rome.
  • Iurlo A; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano.
  • Martino B; Hematology Unit, Azienda Ospedaliera "Bianchi-Melacrino-Morelli", Reggio Calabria.
  • Sgherza N; Casa Sollievo della Sofferenza Hospital, Hematology and Transplant Center, San Giovanni Rotondo.
  • Binotto G; Hematology Unit, University of Padova, Padua.
  • Castagnetti F; Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna.
  • Gozzini A; Hematology Unit, AOU Careggi, University of Florence, Florence.
  • Fozza C; Department of Clinical and Experimental Medicine, University of Sassari, Sassari.
  • Bocchia M; Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena.
  • Sicuranza A; Hematology Unit, Azienda Ospedaliera Universitaria Senese, University of Siena, Siena.
  • Stagno F; Hematology Unit, Ferrarotto Hospital, Catania.
  • Efficace F; Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome.
  • Usala E; Businco Hospital, Hematology and Transplant Center, Cagliari.
  • De Gregorio F; Hematology Unit "Federico II" University of Naples, Naples.
  • Scaffidi L; Department of Medicine, Section of Hematology, University of Verona, Verona.
  • Elena C; Hematology Unit, "Fondazione IRCCS Policlinico S. Matteo" University Hospital, Pavia.
  • Pirillo F; Hematology Unit, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza, Torino.
  • Baratè C; Department of Clinical and Experimental Medicine, Section of Hematology, University of Pisa, Pisa.
  • Trawinska MM; Hematology Unit, Sant'Eugenio Hospital Tor Vergata University, Rome.
  • Cattaneo D; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milano.
  • Labate C; Hematology Unit, Azienda Ospedaliera "Bianchi-Melacrino-Morelli", Reggio Calabria.
  • Gugliotta G; Department of Experimental, Diagnostic and Specialty Medicine, S. Orsola-Malpighi Hospital, University of Bologna, Bologna.
  • Molica M; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Specchia G; Hematology and Transplants Unit, University of Bari, Bari.
  • La Nasa G; Department of Medical Sciences and Public Health, University of Cagliari, Cagliari.
  • Foà R; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto I, Sapienza University, Rome, Italy.
  • Breccia M; Division of Hematology, Department of Cellular Biotechnologies and Hematology, Policlinico Umberto I, Sapienza University, Rome, Italy.
Am J Hematol ; 93(7): E159-E161, 2018 07.
Article en En | MEDLINE | ID: mdl-29633312
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas / Cardiotoxicidad Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Am J Hematol Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Inhibidores de Proteínas Quinasas / Cardiotoxicidad Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Am J Hematol Año: 2018 Tipo del documento: Article